Chromatin Structure of the Lymphocyte Fc Epsilon Receptor Gene (CD23): Identification of an Upstream Transcriptional Enhancer

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2228-2235

  Schubach, William H ^a,b   Horvath, Gary ^b   LeVea, Charles ^b   Tierney, Janet ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR;

ARTICLE; BURKITT LYMPHOMA; CELL CULTURE; CHEMISTRY; CHROMATIN; ELECTROPHORESIS; ENHANCER REGION; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; BURKITT LYMPHOMA; CHROMATIN; ELECTROPHORESIS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; RECEPTORS, IGE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031093541     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Pene, J., I. Chretien, F. Roussel, F. Briere, J. Y. Bonnefoy, and J. E. deVries. 1989. Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (sCD23) J. Cell. Biochem. 39:253.
2. Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen, and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505.
3. Letellier, M., T. Nakajima, G. Pulido-Cejudo, H. Hofstetter, and G. Delespesse. 1990. Mechanism of formation of human IgE-binding factors (soluble CD23). III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity. J. Exp. Med. 172:693.
4. Flores-Romo, L., J. Shields, Y. Humbert, P. Graber, J. P. Aubry, J-F. Gauchat, G. Ayala, B. Allet, M. Chavez, H. Bazin, M. Capron, and J-Y. Bonnefoy. 1993. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261:1038.
5. Lee, W. T., M. Rao, and D. H. Conrad. 1987. The murine lymphocyte receptor for IgE. The mechanism of ligand-specific receptor upregulation on B cells. J. Immunol. 139:1191.
6. Kehry, M. R., and L. C. Yamashita. 1989. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA 86:7556.
7. Pirron, J., T. Schlunck, J. C. Prinz, and P. E. Rieber. 1990. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 20:1547.
8. Bonnefoy, J-Y., S. Henchoz, M. J. Holder, D. Hardie, and J. Gordon. 1993. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:969.
9. Rieber, E. P., G. Rank, I. Kohler, and S. Krauss. 1993. Membrane expression of CD23 and release of soluble CD23 by follicular dendritic cells. Adv. Exp. Med. Biol. 329:393.
10. Thorley-Lawson, D. A., L. M. Nadler, A. K. Bhan, and R. T. Schooley. 1985. Blast-2 (EBVCS), an early cell surface marker of human B cell activation, is superinduced by Epstein Barr Virus. J. Immunol. 134:3007.
11. Kinter, C., and B. Sugden. 1981. Identification of antigenic determinants unique to the surfaces of cells transformed by EBV. Nature 295:458.
12. Defrance, T., J. P. Aubry, F. Rousset, B. Vanbervliet, J-Y. Bonnefoy, N. Arai, Y. Takebe, T. Yokota, F. Lee, K. Arai, J. De Vries, and J. Banchereau. 1987. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 165:1459.
13. Kikutani, H., M. Suemura, H. Owaki, H. Nakamura, R. Sato, K. Yamasaki, E. I. Barsumian, R. R. Hardy, and T. Kishimoto. 1986. Fc epsilon receptor: a specific differentiation marker transiently expressed on mature B cells before isotype switching. J. Exp. Med. 164:1455.
14. Gordon, J., M. Rowe, L. Walker, and G. Guy. 1986. Ligation of the CD23, p45 (BLAST-2, EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes. Eur. J. Immunol. 16:1075.
15. Uchibayashi, N., H. Kikutani, E. L. Barsumian, R. Hauptmann, F-J. Schneider, R. Schwendenwein, W. Sommergruber, N. Spevak, I. Maurer-Fogy, M. Suemure, and T. Kishimoto. 1989. Recombinant soluble Fc∈ receptor II has IgE binding activity but no B cell growth promoting activity. J. Immunol. 142:3901.
16. Cairns, J. A., and J. Gordon. 1990. Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts. Eur. J. Immunol. 20:539.
17. Swendeman, S., and D. A. Thorley-Lawson. 1987. The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells. EMBO J. 6:1637.
18. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55.
19. Aubry, J. P., S. Pochon, J. F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J-Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD23. J. Immunol. 152:5806.
20. Calender, A., M. Billaud, J-P. Aubry, J. Banchereau, M. Vuillaume, and G. M. Lenoir. 1987. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 84:8060.
21. Wang, F., C. D. Gregory, M. Rowe, A. B. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, T. Kishimoto, and E. Kieff. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84:3452.
22. Wang, F., C. Gregory, C. Sample, W. Rowe., D. Liebowitz, R. Murray, A. B. Rickinson, and E. Kieff. 1990. EBV latent membrane protein and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309.
23. Rabson, M., L. Gradoville, L. Heston, and G. Miller. 1982. Non-immortalizing P3HR-1 EBV: a deletion mutant of its transforming parent, Jijoye. J. Virol. 44:834.
24. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of EBV in human B lymphocytes. Nature 340:393.
25. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150.
26. Thorley-Lawson, D. A., and K. P. Mann. 1985. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 162:45.
27. Wang, F., H. Kikutani, S. F. Tsang, T. Kishimoto, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65:4101.
28. Lacy, J., G. Roth, and B. Shieh. 1994. Regulation of the human IgE receptor (FceRII/CD23) by EBV: localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors. J. Immunol. 153:5537.
29. Lacy, J., and H. Rudnick. 1992. Transcriptional regulation of the human IgE receptor (FceRII/CD23) by EBV: identification of EBV-responsive regulatory elements in intron I. J. Immunol. 148:1554.
30. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science 265:92.
31. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jκ recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568.
32. Zimber-Strobl, U., L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai, T. Furukawa, T. Honjo, and G. W. Bornkamm. 1994. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila suppressor of hairless. EMBO J. 13:4973.
33. Hsieh, J. J., and S. D. Hayward. 1995. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268:560.
34. Cohen, J. I., F. Wang, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65:2545.
35. Tong, X., F. Wang, C. J. Thut, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J. Virol. 69:585.
36. Gross, D. S., and W. T. Garrard. 1988. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57:159.
37. Elgin, S. C. R. 1988. The formation and function of DNase I hypersensitive sites in the process of gene activation. J. Biol. Chem. 263:19259.
38. Emerson, B. M., and G. Felsenfeld. 1984. Specific factor conferring nuclease hypersensitivity at the 5′ end of the chicken adult β-globin gene. Proc. Natl. Acad. Sci. USA 81:95.
39. King, W., A. L. T. Powell, N. Raab-Traub, M. Hawke, and E. Kieff. 1980. EBV RNA: V. Viral RNA in a restringently infected, growth-transformed cell line. J. Virol. 36:506.
40. Minowada, J., T. Ohnuma, and G. E. Moore. 1972. Rosette-forming human lymphoid cell lines. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49:891.
41. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565.
42. Kikutani, H., S. Inui, S. Ryoichi, E. L. Barsumian, H. Owaki, K. Yamasaki, T. Kaisho, N. Uchibayashi, R. R. Hardy, T. Hirano, S. Tsunasawa, F. Sakiyama, M. Suemura, and T. Kishimoto. 1986 Molecular structure of the human lymphocyte receptor for immunoglobulin E. Cell 47:657.
43. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
44. Wilkinson, M. 1988. RNA isolation: a mini-prep method. Nucleic Acids Res. 16:10933.
45. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
46. Schubach, W., and M. Groudine. 1984 Alteration of c-myc chromatin structure by avian leukosis virus integration. Nature 307:702.
47. Linial, M., N. Gunderson, and M. Groudine. 1985. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 230:1126.
48. Ponte, P., P. Gunning, H. Blau, and L. Kedes. 1985. Human actin genes are single copy for α-skeletal and α-cardiac actin but multicopy for β- and γ-cytoskeletal genes: 3′ untranslated regions are isotype specific but conserved in evolution. Mol. Cell. Biol. 3:1783.
49. Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33:729.
50. Spaete, R. R., and E. S. Mocarski. 1985. Regulation of cytomegalovirus gene expression: α and β promoters are trans activated by viral functions in permissive human fibroblasts. J. Virol. 56:135.
51. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044.
52. Sambrook, J., T. F. Fritsch, and T. Maniatis. (1989) Molecular Cloning, 2nd Ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
53. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids. Res. 19:2499.
54. Yokota, A., H. Kikutani, T. Tanaka, R. Sato, E. L. Basumian, M. Suemura, and T. Kishimoto. 1988. Two species of human Fc epsilon RII(CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 55:611.
55. Wu, C. 1980. The 5′ ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase 1. Nature 286:854.
56. Robertson, E. S., S. Grossman, E. Johannsen, C. Miller, J. Lin, B. Tomkinson, and E. Kieff. 1995. EBV nuclear protein 3C modulates transcription through interaction with sequence-specific DNA-binding protein Jκ. J. Virol. 69:3108.
57. Dynan, W. S. 1989. Modularity in promoters and enhancers. Cell 58:1.
58. Suter, U., G. Texido, and H. Hofstetter. 1989. Expression of the human IgE receptor (TcERII/CD23), Identification of the FC∈RIIa promoter and its functional analysis in B lymphocytes. J. Immunol. 143:3087.
59. Saffer, J. D., and S. J. Thurston. 1989. A negative regulatory element with properties similar to those of enhancers is contained within an Alu sequence. Mol. Cell. Biol. 9:355.
60. Stalder, J., A. Larsen, J. D. Engel, M. Dolan, M. Groudine, and H. Weintraub. 1980. Tissue-specific DNA cleavages in the globin chromatin domain introduced by Dnase I. Cell 20:451.
61. Stalder, J., M. Groudine, J. B. Dodgson, J. D. Engel, and H. Weintraub. 1980. Hb switching in chickens. Cell 19:973.
62. Krumm, A., T. Meulia, and M. Groudine. 1993. Common mechanisms for the control of eukaryotic transcriptional elongation. BioEssays 15:659.